COSCIENS Biopharma Inc. Key Management Personnel Compensation Postemployment Benefits
COSCIENS Biopharma Inc. (CSCIF) reported Key Management Personnel Compensation Postemployment Benefits of $28.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits · last filed 2026-03-25
- COSCIENS Biopharma Inc. key management personnel compensation postemployment benefits for the quarter ending 2022-03-31 was $18.00K, a 50.00% increase year-over-year.
- COSCIENS Biopharma Inc. key management personnel compensation postemployment benefits for the quarter ending 2021-12-31 was $32.00K, a 28.89% decline year-over-year.
- COSCIENS Biopharma Inc. key management personnel compensation postemployment benefits for the quarter ending 2021-09-30 was $10.00K, a 28.57% decline year-over-year.
- COSCIENS Biopharma Inc. key management personnel compensation postemployment benefits for the quarter ending 2021-06-30 was $16.00K.
| Period end | Key Management Personnel Compensation Postemployment Benefits 3 month | Key Management Personnel Compensation Postemployment Benefits 6 month | Key Management Personnel Compensation Postemployment Benefits 9 month | Key Management Personnel Compensation Postemployment Benefits 12 month |
|---|---|---|---|---|
| 2025-12-31 | $28.00K 20-F · filed 2026-03-25 | |||
| 2024-12-31 | $20.00K 20-F · filed 2026-03-25 | |||
| 2023-12-31 | $37.00K 20-F/A · filed 2024-07-17 | |||
| 2022-12-31 | $63.00K 20-F/A · filed 2024-07-17 | |||
| 2022-03-31 | $18.00K 6-K · filed 2022-05-11 | $50.00K derived: sum of 2 quarters · filed 2024-07-17 | $60.00K derived: sum of 3 quarters · filed 2024-07-17 | $76.00K derived: sum of 4 quarters · filed 2024-07-17 |
| 2021-12-31 | $32.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-07-17 | $42.00K derived: sum of 2 quarters · filed 2024-07-17 | $58.00K derived: sum of 3 quarters · filed 2024-07-17 | $70.00K 20-F/A · filed 2024-07-17 |
| 2021-09-30 | $10.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-11-04 | $26.00K derived: sum of 2 quarters · filed 2021-11-04 | $38.00K 6-K · filed 2021-11-04 | $83.00K derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-06-30 | $16.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-08-05 | $28.00K 6-K · filed 2021-08-05 | $73.00K derived: sum of 3 quarters · filed 2024-02-15 | $87.00K derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-03-31 | $12.00K 6-K · filed 2022-05-11 | $57.00K derived: sum of 2 quarters · filed 2024-02-15 | $71.00K derived: sum of 3 quarters · filed 2024-02-15 | |
| 2020-12-31 | $45.00K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-15 | $59.00K derived: sum of 2 quarters · filed 2024-02-15 | $86.00K 20-F/A · filed 2024-02-15 | |
| 2020-09-30 | $14.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-11-04 | $41.00K 6-K · filed 2021-11-04 | ||
| 2020-06-30 | $27.00K 6-K · filed 2021-08-05 | |||
| 2018-12-31 | $147.00K 20-F · filed 2019-04-01 | |||
| 2017-12-31 | $59.00K 20-F · filed 2019-04-01 | |||
| 2016-12-31 | $78.00K 20-F · filed 2019-04-01 | |||
| 2015-12-31 | $119.00K 20-F · filed 2018-03-28 |